Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Robertet Interim / Quarterly Report 2025

Sep 25, 2025

1630_ir_2025-09-25_9a4ec636-d8c1-43f8-a74a-4bfdc9a5b941.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

{0}------------------------------------------------

{1}------------------------------------------------

CONTENTS

FIRST-HALF 2025
MANAGEMENT REPORT 3
CONSOLIDATED FINANCIAL
STATEMENTS
7
Consolidated statement of income
Consolidated statement of comprehensive income
Consolidated statement of financial position
Consolidated statement of changes in equity
Consolidated statement of cash flows
NOTES TO THE CONSOLIDATED
FINANCIAL STATEMENTS
13
STATUTORY AUDITORS' REVIEW REPORT
ON THE HALF-YEARLY FINANCIAL
INFORMATION
31
STATEMENT BY THE PERSONS
RESPONSIBLE FOR THE INTERIM
FINANCIAL REPORT
33

{2}------------------------------------------------

FIRST-HALF 2025 MANAGEMENT REPORT

Six months ended June 30, 2025

{3}------------------------------------------------

FIRST-HALF 2025 MANAGEMENT REPORT

CONTEXT

In first-half 2025, Robertet continued to fulfill its mission of "Futuring naturals", and delivered an excellent performance.

In an instable and uncertain environment, Robertet continues to draw on its major assets: its expertise in naturals, its agility towards its customers, and the stability of its family shareholder structure.

The geopolitical context remains a cause for concern, creating a prudent, wait-and-see attitude. The flow of goods is disrupted, tariffs are increasing and customers are exercising caution when it comes to inventories.

The effects of currency fluctuations are notable and have been and on the rise for several months, generating a widening gap between our organic performance and reported growth. Nevertheless, inflation and interest rates are declining, there are a number of projects in the pipeline for the launch of new products, and certain regions are showing good momentum.

In the first half of 2025, Robertet recorded revenue of €446.3 million, representing growth of 7.7%, or 7.1% on a constant scope basis. On a comparable exchange rate and scope basis, organic growth came out at 9.2%. In the first quarter of 2025, revenue rose by 5.5% compared with the same period in 2024. Growth picked up further in the second quarter, with revenue up 10.0% on the same period last year.

RESULTS BY DIVISION

The solid first-half 2025 performance mainly reflects strong growth in the Flavors and Raw Materials Divisions, but all Robertet Divisions reported growth during the period.

Raw Materials accounted for 26.3% of revenue, up 14.4%, driven by solid momentum in the fine fragrances market, a slight upturn in the aromatherapy market in the United States and robust demand from customers in Europe and Asia. The Division has represented Robertet's unique expertise for 175 years, and offers its customers a unique catalog of over 1,600 natural products from more than 60 countries.

{4}------------------------------------------------

Fragrances accounted for 35.8% of revenue, up 0.5%, driven by modest growth in Europe and strong growth in South America, the Middle East and Asia. However, the Division was held back by the slowdown in North America attributable to inventory effects at one of our main customers. The Fragrances Division continues to expand sharply with niche brands, including in North America, and in growth markets such as China, Brazil and the Middle East.

The Flavors Division represented 35.3% of revenue, up 10.7%, benefiting from customers seeking natural solutions and unique creations. Demand is strong from both large global customers and regional customers looking for local or original tastes.

Health & Beauty, which accounted for 2.6% of revenue, grew 9.1% over the period. The Division is pursuing its commercial development on the three major continents of Europe, North America and Asia. Its clinically-proven natural active ingredients are winning over dietary supplement brands, as well as beverage and cosmetics brands.

RESULTS BY REGION

Results were driven by strong growth in Europe, Asia and South America, but were stable in North America.

Europe accounted for 48% of Group revenue, with strong double-digit growth across all Divisions and countries. Natural raw materials benefited from a healthy performance for fine fragrances and the upturn of organic products. Flavors saw strong momentum with a number of major international customers.

North America accounted for 34% of Group revenue and delivered very slight organic growth of 0.6%. All Divisions reported robust growth, with the exception of fragrances, which had to contend with significant inventory reductions at a major customer. The rest of the Division continued to grow sharply, with a proactive drive to win new projects. We remain optimistic going forward thanks to our loyal customers comprising major international customers, and our ability to support emerging brands targeting younger generations. During the period we expanded our Creative Center in New York. Our strong local manufacturing footprint is supporting business levels, but price negotiations to reflect new tariffs on our raw materials are currently ongoing.

Latin America accounted for 7% of revenue and is enjoying strong growth. It continues to expand across all countries and Divisions, with fragrances experiencing particularly strong growth in Brazil and Mexico. We continue to gain ground in this region, with high levels of demand from both regional and international groups and brands.

North Asia accounted for 5% of revenue, with strong growth in China and Japan. Raw materials and fragrances are driving this growth, thanks in particular to young, dynamic local brands. China offers great potential for raw materials and fragrances thanks to the growing number of local brands and their increasingly premium positioning. Meanwhile, we are strengthening our organization in the flavors business to ensure that we return to growth.

South Asia and India accounted for 6% of revenue, reporting growth compared with the prior-year period, particularly in Indonesia and in fragrances. The region is a thriving hub of regional family-owned groups looking for original products as well as agile, responsive partners. The acquisition of Sonarome at the end of 2023 gave us a strong foothold in flavors in India, while we are currently building our first production facility in Indonesia to enhance our positioning in this strategic country.

FINANCIAL PERFORMANCE

Recurring EBITDA came to €100.2 million, up 12.7% on the first half of 2024, representing 22.5% of revenue. The improvement in gross margin was due to lower purchase prices and a favorable product mix within our categories.

Recurring operating income grew by 17.0% to €85.2 million. However, it was marked by significant rises in external expenses linked to our major IT projects, as well as higher transportation, travel and personnel costs linked to business growth.

Consolidated net income came to €59 million, up 13.1% compared with the first half of 2024, representing 13.2% of revenue. Lower interest rates led to lower returns on our cash investments as well as a lower cost of debt, resulting in a favorable net finance cost.

{5}------------------------------------------------

SIGNIFICANT EVENTS

Following the arrival of new shareholders in November 2024, the Board of Directors welcomed four new members: two new independent members representing the two new reference shareholders, Fonds Stratégique de Placement and Peugeot Invest Assets, who will support Robertet's future development; and two new directors from the Maubert family, reaffirming the family's long ‑term commitment to Robertet and its desire to remain independent .

Robertet is pursuing a targeted acquisitions strategy with the acquisition of the entire share capital of Phasex in the United States at the end of 2024. The company, which is currently being integrated, provides our North American subsidiary Robertet USA with the capacity to extract American ingredients for the local market. This expertise in the extraction of new technology raw materials will be a key strength in serving our local customers and positioning Robertet as an expert in naturals.

Non-financial performance is also a priority, with a record 64 certified sourcing channels, while water consumption and CO 2 emissions are decreasing. We have also set up an ethics committee to promote a sustainable business climate among our internal and external stakeholders. During the period, we were awarded a Ecovadis Platinum medal and continued to improve our EthiFinance score, demonstrating performance of our teams across all these sustainable development issues.

Robertet is strengthening its global presence by investing in its industrial capacity in Indonesia and Mexico, as well as opening new creative centers to host our customers and our creative and sales teams. At the start of 2025, we doubled our presence in New York and Dubai and inaugurated our new creative centers in Shanghai, Singapore and Mexico City.

Our Grasse-based start-up accelerator – dedicated to natural products – is enjoying strong success, with nearly 20 resident companies benefiting from our support in developing their projects and products and accessing the market and financing. Embodying our vertical "Seed to Scent" business model, these start-ups are pioneering the naturals of the future, proving each day the enduring appeal and resilience of natural products .

We are also continuing to invest heavily in our industrial facilities and IT systems, and in expanding our premises and workforce to prepare for future growth.

Our solid first-half 2025 revenue performance supports our organic revenue growth objective for full-year 2025, in line with our 2030 targets, i.e., growth of between 5% and 7%.

JÉRÔME BRUHAT

Chief Executive Officer

{6}------------------------------------------------

CONSOLIDATED FINANCIAL STATEMENTS

Six months ended June 30, 2025

{7}------------------------------------------------

CONSOLIDATED STATEMENT OF INCOME

In thousands of euros Note June 30,
2024
Dec. 31,
2024
June 30,
2025
Revenue 12 414,579 807,609 446,337
REVENUE FROM ORDINARY ACTIVITIES 414,579 807,609 446,337
Other operating income 14 3,788 4,820 3,216
Purchases used in production (179,628) (352,422) (182,054)
External charges (57,676) (116,628) (65,108)
Personnel costs (87,136) (177,856) (97,539)
Taxes other than on income (5,009) (8,457) (4,629)
Additions to/reversals from depreciation, amortization and provisions 13 (15,334) (31,242) (14,498)
Impairment of trade receivables, other receivables and contract assets 13 (690) (450) (449)
Other operating expenses 14 (86) (117) (88)
RECURRING OPERATING INCOME 12 72,808 125,256 85,187
Asset disposals 243 (162) (49)
OPERATING INCOME 73,052 125,094 85,138
Share of net income of companies accounted for by the equity method 221 380 279
OPERATING INCOME AFTER SHARE OF NET INCOME OF
COMPANIES ACCOUNTED FOR BY THE EQUITY METHOD
73,272 125,474 85,417
Income from cash and cash equivalents 2,914 5,649 2,410
Gross cost of debt (6,432) (11,350) (4,749)
Net finance costs 15 (3,519) (5,701) (2,339)
Other financial income and expenses 15 (702) 1351 (3,354)
INCOME BEFORE TAX 69,052 121,124 79,724
Current and deferred taxes 16 (16,907) (30,545) (20,743)
CONSOLIDATED NET INCOME 52,145 90,580 58,981
Net income attributable to non-controlling interests 456 511 480
NET INCOME (attributable to owners of the company) 12 51,688 90,068 58,501
Basic earnings per share (in euros) 18 24.71 43.06 28.55
Diluted earnings per share (in euros) 18 24.71 43.06 28.55

{8}------------------------------------------------

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

In thousands of euros Note June 30,
2024
Dec. 31,
2024
June 30,
2025
CONSOLIDATED NET INCOME 52,145 90,580 58,981
Items that may be reclassified to income 6,349 10,159 (34,002)
Change in foreign currency translation adjustments SCIE1 5,882 11,127 (33,881)
Interest rate swaps 630 (1,304) (164)
Tax on interest rate swaps (163) 337 42
Items that will not be reclassified to income 168 62 59
Remeasurement of the net defined benefit liability (asset) 9 246 84 80
Tax on remeasurement of the net defined benefit liability (asset) (78) (23) (21)
TOTAL COMPREHENSIVE INCOME SCIE1 58,662 100,800 25,038
Attributable to Robertet SA shareholders SCIE1 58,192 100,252 24,794
Attributable to non-controlling interests SCIE1 470 548 244

1 SCIE: Consolidated statement of changes in equity.

{9}------------------------------------------------

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

In thousands of euros Note Dec. 31, 2024 June 30, 2025
NON-CURRENT ASSETS 389,994 389,857
Goodwill 3 83,154 82,290
Intangible assets 4.1 78,773 76,681
Property, plant and equipment 4.2 178,252 173,446
Right-of-use assets 4.3 22,885 22,213
Financial assets 5 16,417 25,621
Investments in associates 3,768 3,877
Deferred taxes 16 6,744 5,730
CURRENT ASSETS 618,192 617,642
Inventories and work in progress 6 239,958 238,291
Trade receivables 7 155,994 180,173
Other receivables and accruals 8 22,826 27,718
Current tax assets 8 3,069 3,631
Other current financial assets 35,334 18,356
Cash and cash equivalents 17 158,133 146,637
Assets held for sale 2,878 2,836
TOTAL ASSETS 1,008,186 1,007,499
EQUITY 552,112 557,438
Share capital 5,764 5,423
Share premium 67,218 67,218
Consolidated reserves 478,824 484,797
Equity (attributable to owners of the Company) 551,805 557,438
Non-controlling interests 307 -
NON-CURRENT LIABILITIES 257,511 254,241
Non-current provisions 9 792 1,209
Non-current employee benefits 9 11,353 11,439
Non-current financial liabilities 10.1 201,182 197,147
Non-current lease liabilities 10.2 18,337 17,737
Deferred taxes 16 25,847 26,709
CURRENT LIABILITIES 198,562 195,820
Current provisions 9 1,852 1,674
Current employee benefits 9 1,386 1,472
Current financial liabilities 10.1 66,111 65,773
Current lease liabilities 10.2 5,526 5,445
Current tax liabilities 10,449 3,893
Trade payables 62,867 67,394
Other current liabilities 11 47,494 47,333
Liabilities held for sale 2,879 2,836
TOTAL EQUITY AND LIABILITIES 1,008,186 1,007,499

{10}------------------------------------------------

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

In thousands of euros Share
capital
Share
premium
Consolidated
reserves
Cumulative
foreign
currency
translation
adjustments
Own
shares
Equity
attributable
to owners of
the Company
Non
controlling
interests
Total
equity
BALANCE
AT DECEMBER 31,
20231
5,764 61,945 603,247 (1,238) (204,031) 465,687 906 466,593
Net income 51,688 51,688 456 52,145
Other comprehensive income 644 5,860 6,503 14 6,517
Total comprehensive income 52,332 5,860 58,192 470 58,662
Dividends paid (17,779) (17,779) - (17,779)
Transactions with non
controlling interests and
changes in liabilities for
put options over minority
interests2
(1,967) (1,967) 51 (1,916)
Allocation of free shares 1,314 1,314 - 1,314
Other movements 5,273 (4,867) 406 - 406
Total other movements in
equity
5,273 (23,299) (18,026) 51 (17,976)
BALANCE
AT JUNE 30, 2024
5,764 67,218 632,280 4,622 (204,031) 505,853 1,427 507,280
BALANCE
AT DECEMBER 31,
2024
5,764 67,218 673,002 9,852 (204,031) 551,805 307 552,112
Net income 58,501 58,501 480 58,981
Other comprehensive income (62) (33,644) (33,707) (237) (33,943)
Total comprehensive income 58,438 (33,644) 24,794 244 25,038
Dividends paid (20,960) (20,960) (20,960)
Transactions with non
controlling interests and
changes in liabilities for
put options over minority
interests3
417 417 (551) (133)
Allocation of free shares 1,056 1,056 1,056
Capital reduction (341) 341
Other movements 326 326 326
Total other movements in
equity
(341) (19,161) 341 (19,161) (551) (19,712)
BALANCE
AT JUNE 30, 2025
5,423 67,218 712,279 (23,792) (203,690) 557,438 - 557,438

(1) Amounts reported in the 2023 consolidated financial statements as of December 31, 2023, restated to reflect the retrospective application of provisional goodwill relating to the Sonarome business combination.

(2) Transactions with non-controlling interests in first-half 2024 mainly concerned:

the change in fair value of the put option on minority interests representing 40% of the capital of Astier Demarest, for a negative impact of €1,677 thousand;

the change in fair value of the put option on minority interests representing 15% of the capital of Sonarome, for a negative impact of €124 thousand.

(3) Transactions with non-controlling interests in first-half 2025 mainly concerned:

the acquisition of shares in Robertet Group Indonesia, increasing the Robertet Group's stake from 67% to 100%, for a negative impact of €133 thousand.

{11}------------------------------------------------

CONSOLIDATED STATEMENT OF CASH FLOWS

In thousands of euros Note June 30,
2024
Dec. 31,
2024
June 30,
2025
Consolidated net income 12 51,688 90,068 58,501
Net income attributable to non-controlling interests 456 511 480
Elimination of net income of companies accounted for by the equity method (71) (230) (109)
Depreciation and amortization 13 13,301 24,601 14,419
Net additions to provisions 1,486 2,899 700
(Gain)/Loss on disposal of assets (243) 162 49
Income and expenses with no cash impact 2,187 2,167 1,056
Income tax expense (current and deferred taxes) 16 16,864 30,479 20,747
Net cost of debt 3,293 1,953 1,439
Effect of hyperinflation 385 1,108 39
Cash flow from operations before net cost of debt and income tax 89,348 153,718 97,321
Interest paid (6,439) (11,499) (4,850)
Interest received 3,140 9,396 3,306
Income tax paid (14,676) (29,776) (26,573)
Cash flow from operations after net cost of debt and income tax 71,372 121,839 69,204
Change in inventories 6 2,999 (6,176) (9,955)
Change in trade and other receivables 7 (38,796) (15,394) (36,068)
Change in trade and other payables 10,488 12,145 9,524
Impact of change in working capital 17 (25,310) (9,425) (36,499)
NET CASH FROM OPERATING ACTIVITIES 46,063 112,414 32,706
Industrial investments 4 (15,613) (38,595) (16,894)
Financial investments (8,277) (6,379) 303
Asset disposals 9,242 11,972 3,444
Acquisition of subsidiaries, net of cash acquired (16) (5,330) (2,089)
NET CASH USED IN INVESTING ACTIVITIES (14,663) (38,333) (15,236)
Dividends paid by the parent company SCIE1 (17,779) (17,779) (20,960)
Proceeds from new borrowings 6,236 10,203 5,091
Repayments of borrowings (6,431) (52,623) (10,656)
Increase in other financial liabilities 3,546 7,581 6,156
Decrease in other financial liabilities (2,534) (6,312) (1,775)
NET CASH USED IN FINANCING ACTIVITIES (16,963) (58,930) (22,145)
IMPACT OF CURRENCY FLUCTUATIONS ON CASH
AND CASH EQUIVALENTS
533 1,480 (8,264)
NET INCREASE/(DECREASE) IN CASH AND CASH
EQUIVALENTS
14,969 16,630 (12,940)
Net cash at beginning of period 139,280 139,280 155,910
Net cash at end of period 17 154,249 155,910 142,970

1 SCIE: Consolidated statement of changes in equity.

{12}------------------------------------------------

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Six months ended June 30, 2025

{13}------------------------------------------------

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – GENERAL INFORMATION, SIGNIFICANT EVENTS OF THE PERIOD AND EVENTS AFTER THE REPORTING DATE

1.1. General information

The Robertet Group's condensed consolidated financial statements for the first half of 2025 include Robertet SA, the parent company, and its subsidiaries. Robertet, also referred to as "the Group", specializes in the creation, production and distribution of aromatic products intended mainly for the fragrances and food industries.

Robertet SA, the parent company (also referred to as "the Company") is a public limited company (société anonyme) incorporated under French law, and is listed on the Paris Stock Exchange (Euronext compartment B). Its head office is located at 37 avenue Sidi Brahim in Grasse.

The condensed consolidated financial statements for the first half of 2025 were approved for issue by the Board of Directors on September 10, 2025.

1.2 Significant events of the period

On January 4, 2025, Robertet Africa merged with Robertet SA via a universal asset transfer. Robertet SA generated a merger bonus of €301 thousand, which was allocated in full to financial income.

On February 26, 2025, Robertet SA reduced its share capital from €5,763,972.50 to €5,423,242.50 by cancelling 136,292 treasury shares, representing €340,730.00.

1.3. Events after the reporting date

No significant events that would alter the disclosures in these financial statements occurred between the reporting date, as of June 30, 2025, and the date of the Board of Directors' meeting at which these financial statements were approved for issue, on September 10, 2025.

A process to put the Sirius entity up for sale was launched in July 2024 and was still ongoing at the reporting date.

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2.1. Basis of preparation of the consolidated financial statements

Because it is listed in a European Union country, in accordance with EC regulation 1606/2002 of July 19, 2002, the Robertet Group's consolidated financial statements have been prepared and published in accordance with International Financial Reporting Standards (IFRS), as adopted by the European Union. These include the IFRS approved by the International Accounting Standards Board (IASB), the International Accounting Standards (IAS) and the interpretations issued by the International Financial Reporting Interpretations Committee (IFRIC).

The condensed interim consolidated financial statements at June 30, 2025 were prepared in accordance with IAS 34 – Interim Financial Reporting. Pursuant to IAS 34, only a selection of explanatory notes is included in these condensed financial statements. These notes should be read in conjunction with the consolidated financial statements for the year ended December 31, 2024. The accounting policies are identical to those applied for said consolidated financial statements.

For the presentation of the condensed interim consolidated financial statements for the period ended June 30, 2025, the Group has applied the following new standards and interpretations which have been adopted by the European Union and whose application was mandatory for the first-time for annual financial periods beginning on or after January 1, 2025:

Standards, amendments and interpretations with mandatory application from January 1, 2025

• Amendment to IAS 21 – The Effects of Changes in Foreign Exchange Rates: Lack of Exchangeability, issued on August 15, 2023.

These new standards and amendments did not have a material impact on the Group's consolidated financial statements.

Standards, amendments and interpretations not yet applicable at January 1, 2025

  • Amendments to IFRS 9 and IFRS 7 Amendments to the Classification and Measurement of Financial Instruments, issued by the IASB on May 30, 2024.
  • Amendments to IFRS 9 and IFRS 7 Contracts Referencing Nature-dependent Electricity, issued by the IASB on December 18, 2024.
  • Annual improvements to IFRS 1, IFRS 7, IFRS 9, IFRS 10 and IAS 7, published by the IASB on July 18, 2024.
  • IFRS 18 Presentation and Disclosure in Financial Statements, published by the IASB on April 9, 2024.
  • IFRS 19 Subsidiaries without Public Accountability: Disclosures, published by the IASB on May 9, 2024.

{14}------------------------------------------------

The Group has chosen not to early adopt these standards and amendments, but has begun to analyze the impacts of their application. The Group will apply these standards in its financial statements once they have been adopted by the European Union.

2.2. Use of estimates

The preparation of financial statements in accordance with IFRS requires the use of estimates and assumptions that affect the amounts reported in the financial statements. The main areas where estimates and assumptions are used are the methods applied to identify and measure intangible assets in business combinations, impairment of non-financial assets, employee benefits, provisions for contingencies, impairment of inventories and receivables, and determining the lease term and lease payments included in calculating lease liabilities.

These estimates are based on the best information available to Management at the reporting date. Changes in estimates and assumptions could have an impact on the amounts recognized in the financial statements.

2.3. Consolidation methods

In accordance with IFRS 10, the Group's consolidated financial statements include the accounts of all companies directly or indirectly controlled by Robertet SA, regardless of its level of ownership in their equity and the accounts of all associates or companies over which it exercises significant influence.

Subsidiaries (controlled companies) are fully consolidated. Companies over which Robertet SA exercises joint control or significant influence are accounted for using the equity method.

Shares in companies that do not meet these criteria are recorded as equity investments.

Intercompany receivables, payables, income and expenses are eliminated in full on consolidation, as are gains and losses on intercompany transactions (dividends, capital gains and losses, inventory margins, etc.).

All of the companies included in the Group's consolidated financial statements have a June 30 period-end.

The financial statements of foreign entities whose functional currency is not the euro are translated into euros at the period-end exchange rate, and their income statements and cash flow statements are translated at the average exchange rate for the period. The related translation gains or losses are recorded in other comprehensive income under foreign currency translation adjustments within "Consolidated reserves".

Under IAS 29, Argentina and Turkey have been on the list of hyperinflationary economies since 2018 and 2022, respectively.

Pursuant to this standard, the following accounting treatment has been applied to the financial statements of Group subsidiaries operating in these countries:

  • non-monetary balance sheet items are restated by applying a general price index;
  • statement of income and comprehensive income items in local currency are restated by applying the change in the general price index from the initial recording of income and expense items in the financial statements;
  • the balance sheet, statement of income and statement of comprehensive income are translated into euros at the period-end exchange rate;
  • the restatement of reserves for the indexation of equity items of subsidiaries in these countries are included in "Change in foreign currency translation adjustments" in the statement of comprehensive income.

2.4. Description of the principal risks and uncertainties for the second half of 2025

The risk factors relating to the Group's business segment and human resources, financial and environmental risks are of the same nature as those set out in the management report included in the 2024 Annual Financial Report and have not changed significantly over the first half of 2025.

2.5. Transactions with related parties

Information on related parties is provided in note 19, which presents the main developments during the period.

{15}------------------------------------------------

NOTE 3 – GOODWILL

Goodwill recognized in the statement of financial position breaks down as follows:

In thousands of euros Dec. 31, 2024 June 30, 2025
FLAVORS DIVISION
Gross value 37,424 37,424
Impairment
Net value 37,424 37,424
FRAGRANCES DIVISION
Gross value 17,808 17,808
Impairment
Net value 17,808 17,808
RAW MATERIALS DIVISION
Gross value 23,534 22,669
Impairment
Net value 23,534 22,669
HEALTH & BEAUTY DIVISION
Gross value 4,389 4,389
Impairment
Net value 4,389 4,389
TOTAL NET VALUE 83,154 82,290

Changes in the net values of goodwill can be analyzed as follows:

In thousands of euros Dec. 31, 2024 June 30, 2025
Net carrying amount at beginning of period 81,517 83,154
Acquisitions 1,346
Translation adjustments 291 (865)
TOTAL 83,154 82,290

An analysis of goodwill did not indicate any impairment at June 30, 2025.

{16}------------------------------------------------

NOTE 4 – INTANGIBLE ASSETS, PROPERTY, PLANT AND EQUIPMENT AND RIGHT-OF-USE ASSETS

4.1. INTANGIBLE ASSETS

Intangible
assets
(in thousands of
euros)
Value at
Dec. 31, 2024
Translation
adjustments
Acquisitions Disposals Other
movements
Value at
June 30, 2025
Gross value 93,293 (2,108) 1,901 (13) (11) 93,062
Amortization
(in thousands of
euros)
Value at
Dec. 31, 2024
Translation
adjustments
Additions Reversals Other
movements
Value at
June 30, 2025
Amortization 14,520 (581) 2,510 (12) (57) 16,381
NET VALUE 78,773 76,681
Intangible
assets
(in thousands of
euros)
Value at
Dec. 31, 20231
Translation
adjustments
Acquisitions Disposals Other
movements
Value at
June 30, 2024
Gross value 88,753 805 278 - 3,008 92,844
Amortization
(in thousands of
euros)
Value at
Dec. 31, 2023
Translation
adjustments
Additions Reversals Other
movements
Value at
June 30, 2024
Amortization 8,837 57 2,352 - 1,144 12,390

1 Amounts reported in the consolidated financial statements as of December 31, 2023, restated to reflect the retrospective application of provisional goodwill relating to the Sonarome business combination.

4.2. PROPERTY, PLANT AND EQUIPMENT

Property, plant
and equipment
(in thousands of
euros)
Value at
Dec. 31, 2024
Translation
adjustments
Acquisitions Disposals Other
movements
Value at
June 30, 2025
Land and improvements 32,251 (697) 68 31,622
Buildings 200,179 (8,864) 6,231 (52) 197,493
Technical installations 183,564 (6,981) 4,279 (458) 503 180,908
Other PPE 41,533 (2,713) 726 (186) 62 39,422
Assets
in progress
23,563 (545) (525) 165 22,658
TOTAL 481,090 (19,800) 10,710 (643) 746 472,103

{17}------------------------------------------------

Depreciation
(in thousands of
euros)
Value at
Dec. 31, 2024
Translation
adjustments
Additions Reversals Other
movements
Value at
June 30, 2025
Land and
improvements
4,379 (33) 163 5 4,514
Buildings 108,239 (4,720) 3,378 59 106,956
Technical installations 154,237 (5,653) 4,026 (337) 272 152,546
Other PPE 35,982 (2,273) 1,105 (193) 19 34,641
TOTAL 302,838 (12,679) 8,672 (530) 356 298,657
NET VALUE 178,252 173,446
Property, plant
and equipment
(in thousands of
euros)
Value at
Dec. 31, 20231
Translation
adjustments
Acquisitions Disposals Other
movements
Value at
June 30, 2024
Land and
improvements
31,962 (115) 48 490 32,385
Buildings 193,845 1,404 1,496 (27) 82 196,799
Technical installations 194,310 1,082 2,346 (39) (21,519) 176,179
Other PPE 21,064 335 315 (64) 19,209 40,859
Assets
in progress
7,813 63 4,988 (232) 12,632
TOTAL 448,993 2,769 9,193 (130) (1,971) 458,854
Depreciation
(in thousands of
euros)
Value at
Dec. 31, 2023
Translation
adjustments
Additions Reversals Other
movements
Value at
June 30, 2024
Land and
improvements
4,092 222 5 4,320
Buildings 100,424 972 3,091 (27) 430 104,891
Technical installations 162,829 1,071 3,517 (38) (17,092) 150,287
Other PPE 16,944 349 1,718 (35) 16,076 35,052
TOTAL 284,290 2,393 8,548 (100) (580) 294,550
NET VALUE 164,703 164,304

1 Amounts reported in the consolidated financial statements as of December 31, 2023, restated to reflect the retrospective application of provisional goodwill relating to the Sonarome business combination.

{18}------------------------------------------------

4.3. RIGHT-OF-USE ASSETS

Movements in right-of-use assets in first-half 2024 and 2025 can be analyzed as follows:

Right-of-use assets
(in thousands of euros)
Value at
Dec. 31, 2024
Translation
adjustments
Acquisitions Disposals Other
movements
Value at
June 30, 2025
Buildings 32,399 (2,350) 2,544 (789) (87) 31,717
Technical installations 10,908 (930) 1,009 (84) 10,903
Other PPE 8,176 (188) 729 (754) 7,963
TOTAL 51,483 (3,468) 4,282 (1,543) (170) 50,584
Depreciation
(in thousands of euros)
Value at
Dec. 31, 2024
Translation
adjustments
Additions Reversals Other
movements
Value at
June 30, 2025
Buildings 16,924 (1,180) 2,139 (707) (123) 17,053
Technical installations 6,644 (533) 301 (84) 6,328
Other PPE 5,030 (114) 797 (699) (24) 4,990
TOTAL 28,598 (1,827) 3,237 (1,406) (231) 28,371
NET VALUE 22,885 22,213
Right-of-use assets
(in thousands of euros)
Value at
Dec. 31, 2023
Translation
adjustments
Acquisitions Disposals Other
movements
Value at
June 30, 2024
Buildings 21,221 (67) 5,521 (30) 54 26,700
Technical installations 13,115 231 333 (2) (12) 13,665
Other PPE 8,330 9 571 (431) 56 8,534
TOTAL 42,667 173 6,425 (463) 98 48,899
Depreciation
(in thousands of euros)
Value at
Dec. 31, 2023
Translation
adjustments
Additions Reversals Other
movements
Value at
June 30, 2024
Buildings 14,390 (126) 1,370 (30) 54 15,657
Technical installations 8,746 133 289 (2) (12) 9,154
Other PPE 4,912 16 677 (431) 56 5,229
TOTAL 28,048 22 2,335 (463) 98 30,040
NET VALUE 14,619 18,859

The residual expense for lease payments at June 30, 2025 was €1.7 million (versus €1.1 million at June 30, 2024) and corresponds to payments under leases that are not recorded in the statement of financial position in accordance with the accounting principles and exemptions provided for in IFRS 16.

{19}------------------------------------------------

NOTE 5 – NON-CURRENT FINANCIAL ASSETS

In thousands of euros Dec. 31, 2024 June 30, 2025
Equity investments 2,890 2,948
Receivables related to equity investments 5,219 4,760
Other long-term investments1 1,093 11,146
Loans 45 61
Other financial assets 7,170 6,707
TOTAL 16,417 25,621

1 Corresponding to long-term investments of the American subsidiary Robertet USA Inc.

NOTE 6 – INVENTORIES

Inventories can be analyzed as follows:

In thousands of euros Dec. 31, 2024 June 30, 2025
Raw materials 162,289 158,482
Work in progress and finished goods 85,329 87,313
Gross value 247,618 245,796
Impairment (7,660) (7,505)
NET VALUE 239,958 238,291

Impairment losses can be analyzed as follows:

In thousands of euros Dec. 31, 2024 June 30, 2025
AT BEGINNING OF PERIOD 8,069 7,660
Increases 4,918 3,376
Reversals and utilizations (3,606) (3,448)
Translation adjustments 120 (575)
Other movements (1,841) 492
AT END OF PERIOD 7,660 7,505

{20}------------------------------------------------

NOTE 7 – TRADE RECEIVABLES

Trade receivables break down by geographical area as follows:

In thousands of euros Dec. 31, 2024 June 30, 2025
Europe 58,568 74,351
North America 49,044 59,073
South America 18,703 14,450
Asia 25,979 27,546
Other countries 13,400 14,645
TOTAL GROSS RECEIVABLES 165,694 190,066
Impairment (9,700) (9,892)
TOTAL NET RECEIVABLES 155,994 180,173

Impairment of trade receivables can be analyzed as follows:

In thousands of euros Dec. 31, 2024 June 30, 2025
AT BEGINNING OF PERIOD 9,643 9,700
Increases 1,335 657
Changes in scope of consolidation 13 -
Reversals and utilizations (1,261) (208)
Translation adjustments - (147)
Other movements (29) (111)
AT END OF PERIOD 9,700 9,892

NOTE 8 – OTHER CURRENT ASSETS

Other current assets break down as follows:

In thousands of euros Dec. 31, 2024 June 30, 2025
Prepaid expenses 6,096 9,659
Other receivables 16,730 18,059
Total other receivables and accruals 22,826 27,718
Current tax assets 3,069 3,631
TOTAL 25,895 31,348

{21}------------------------------------------------

NOTE 9 – PROVISIONS AND EMPLOYEE BENEFITS

In thousands of euros At beginning
of period
Additions Utilizations Changes in
exchange rates
Other
movements
At
end of
period
Retirement benefits1 9,667 358 (97) (5) 9,923
Other employee benefit obligations2 3,071 114 (108) (89) 2,988
Other risks3 2,644 724 (467) (18) 2,883
TOTAL PROVISIONS AND
EMPLOYEE BENEFITS
15,382 1,196 (575) (204) (5) 15,794
Of which current liabilities 3,237 3,146
Of which recorded in non-current
liabilities
12,145 12,648

1 The Group contributes to constituting pensions for its employees in accordance with the laws and practices of the countries in which its companies operate. It also has certain contractual obligations for supplementary pensions, statutory retirement bonuses and personal risk insurance. The corresponding actuarial liabilities are assumed either in the form of contributions paid to independent organizations responsible for managing and servicing the funds, or in the form of provisions.

Since provisions for retirement benefits in France represent 92.1% of the Group's total provisions, only the discount rates applied to the Group's obligations in France are detailed below. They are determined based on the yield on investment-grade corporate bonds (AA10+ Iboxx index) at the period-end, i.e., 3.45%.

June 30, 2024 Dec. 31, 2024 June 30, 2025
Discount rate 3.60% 3.35% 3.45%

NOTE 10 – FINANCIAL LIABILITIES

10.1 FINANCIAL LIABILITIES

Analysis by type of liability (in thousands of euros) Dec. 31, 2024 June 30, 2025
Bank borrowings 240,327 236,961
Bank overdrafts 2,223 3,666
Other financial liabilities1 23,158 19,629
Shareholder current accounts 1,585 2,663
TOTAL 267,293 262,920

1 At the end of the period, other financial liabilities included:

  • A financial liability of €2,200 thousand in respect of a put option on 10% of the capital of Astier Demarest, exercisable on December 31, 2027 (financial liability of €2,106 thousand at December 31, 2024).
  • A financial liability of €2,492 thousand in respect of the acquisition of the Maverick Group (Omega Ingredients) in 2022, related to an earn-out clause (financial liability of €5,634 thousand at December 31, 2024).
  • A financial liability of €9,885 thousand in respect of a put option on 15% of the capital of Sonarome, put in place on December 1, 2023 (financial liability of €10,572 thousand at December 31, 2024).

2 Other employee benefit obligations mainly correspond to a provision for retirement benefits for the Mexican entity, which must be paid to any employee leaving the company except in the event of resignation. Payment of these severance benefits to an employee who is dismissed by the company constitutes a settlement agreement.

3 Other risks mainly correspond to employee-related, tax and commercial risks. Each known dispute in which Robertet or Group companies are involved was examined at the reporting date and, based on the advice of legal counsel, the provisions deemed necessary were set aside to cover the estimated risks.

{22}------------------------------------------------

The breakdown between fixed and variable rate borrowings is as follows (considering the use of hedging instruments):

In thousands of euros Dec. 31, 2024 June 30, 2025
Fixed-rate borrowings 132,839 133,259
Variable-rate borrowings 107,488 103,702
TOTAL 240,327 236,961
Analysis by repayment schedule and by currency
(in thousands of euros)
Dec. 31, 2024 June 30, 2025
Less than one year 66,111 65,773
Between one
and five years
185,568 183,142
Beyond five years 15,614 14,005
TOTAL 267,293 262,920
Of which in euros 234,319 237,545
Of which in US dollars 14,149 11,914
Of which in other currencies 18,825 13,461

The breakdown of borrowings due in less than one year is as follows:

Breakdown of current liabilities (in thousands of euros) Dec. 31, 2024 June 30, 2025
Current portion of borrowings 60,044 59,438
Current portion of other financial liabilities 3,843 2,668
Bank overdrafts 2,223 3,666
TOTAL 66,111 65,773

Repayments of borrowings in the first half of 2025 amounted to €10,656 thousand, compared with €6,431 thousand in the first half of 2024 and €52,623 thousand in full-year 2024. Proceeds from new borrowings amounted to €5,091 thousand. Certain borrowings taken out by the parent company and Robertet USA Inc. are subject to covenants.

For Robertet SA, these borrowings represented an amount of €187,261 thousand at the end of the period. The consolidated EBITDA/consolidated net debt ratios set out in the covenants were complied with. In addition, three swaps are in place to hedge these borrowings: the first was set up in September 2022 and covered 50% of the simplified public offering loan at a fixed rate of 2.605%. The second was set up on June 14, 2024 and covered 50% of the loan linked to the Sonarome acquisition at a fixed rate of 2.95%.The third was set up on August 1, 2024 to extend financial coverage to 75% of the simplified public offering loan and 75% of the loan linked to the Sonarome acquisition at a fixed rate of 2.65%.

Lastly, Robertet USA Inc. has a loan with the US bank PNC Bank, which is subject to covenants. The outstanding principal stood at \$8.1 million (€6.9 million) at the period-end. At June 30, 2025, the entity was compliant with the leverage and debt service coverage ratios stipulated in the contract.

{23}------------------------------------------------

10.2. LEASE LIABILITIES

This item corresponds to the Group's financial liabilities arising on all of its leases recognized in accordance with IFRS 16.

In thousands of
euros
At beginning
of period
New contracts
and renewals
Repayments
and cancellations
Changes
in scope of
consolidation
and other
movements
Translation
adjustments
At
end of
period
Lease liabilities 23,863 4,134 (3,133) 56 (1,739) 23,181
Of which current
liabilities
5,526 5,445
Of which
non-current liabilities
18,337 17,737
Analysis by repayment schedule (in thousands of euros) Dec. 31, 2024 June 30, 2025
Due in less than one year 5,526 5,445
Due in between one and five years 12,256 12,188
Due in more than five years 6,081 5,549
TOTAL 23,863 23,181
Of which in euros 4,363 4,676
Of which in US dollars 11,009 9,309
Of which in other currencies 8,492 9,195

NOTE 11 – OTHER CURRENT LIABILITIES

The Group's other current liabilities broke down as follows at the period-end:

In thousands of euros Dec. 31, 2024 June 30, 2025
Tax and social security liabilities 34,941 32,543
Other payables 5,848 7,683
Deferred income 6,704 7,107
TOTAL 47,494 47,333

{24}------------------------------------------------

NOTE 12 – SEGMENT REPORTING

In accordance with IFRS 8, the Group reports segment information below in a manner consistent with the internal reporting used by its chief operating decision‑maker and Jérôme Bruhat, Chief Executive Officer of the Robertet Group.

The Group's operating segments as defined under IFRS correspond to its business. Internal reporting to the chief operating decision-maker and Executive Management is based on the following four operating segments, referred to internally as "Divisions":

  • Raw Materials
  • Fragrances
  • Flavors
  • Health & Beauty
At June 30, 2025 Total Raw Materials Fragrances Flavors Health & Beauty
Consolidated revenue 446,337 117,294 159,741 157,659 11,643
Recurring EBITDA 100,222 24,818 28,549 45,556 1,300
Recurring operating income 85,187 20,375 24,556 39,331 924
Net income attributable to owners of the
Company
58,501 12,759 17,903 28,061 (222)
Goodwill 82,290 22,669 17,808 37,424 4,389
Property, plant and equipment and right-of-use
assets
195,658 58,247 54,494 78,799 4,119
At June 30, 2024 Total Raw Materials Fragrances Flavors Health & Beauty
Consolidated revenue 414,579 102,554 158,918 142,436 10,671
Recurring EBITDA 88,919 14,347 39,289 32,065 3,218
Recurring operating income 72,808 10,577 32,971 26,439 2,820
Net income attributable to owners of the
Company
51,688 6,497 23,904 19,213 2,074
Goodwill 81,710 22,089 17,808 37,424 4,389
Property, plant and equipment and right-of-use
assets
183,162 38,530 77,717 62,790 4,124
At December 31, 2024 Total Raw Materials Fragrances Flavors Health & Beauty
Consolidated revenue 807,609 195,823 318,368 272,253 21,166
Recurring EBITDA 157,066 24,937 70,004 58,959 3,165
Recurring operating income 125,256 13,485 62,532 46,850 2,388
Net income attributable to owners of the
Company
90,068 7,524 47,081 34,182 1,281
Goodwill 83,154 23,534 17,808 37,424 4,389
Property, plant and equipment and right-of-use
assets
201,137 57,336 60,059 79,982 3,760

{25}------------------------------------------------

NOTE 13 – DEPRECIATION, AMORTIZATION AND PROVISIONS

In thousands of euros June 30, 2024 Dec. 31, 2024 June 30, 2025
Amortization and depreciation of non-current assets 13,678 27,933 14,590
Additions to and reversals of provisions1 2,346 3,759 357
TOTAL 16,024 31,692 14,947

1 Additions to and reversals of provisions relate to receivables, inventories and provisions for contingencies and charges (see notes 6, 7 and 9).

NOTE 14 – OTHER OPERATING INCOME AND EXPENSES

In thousands of euros June 30, 2024 Dec. 31, 2024 June 30, 2025
Capitalized production - 21 18
Operating subsidies 866 2,413 852
Other operating income 2,893 2,175 2,250
Other non-recurring income 29 212 96
TOTAL OTHER OPERATING INCOME 3,788 4,820 3,216
Other non-recurring expenses (86) (117) (88)
TOTAL OTHER OPERATING EXPENSES (86) (117) (88)

The liability relating to the earn-out clause applied to the acquisition of the Maverick group (Omega Ingredients) (see note 10.1) of which the Robertet Group took control in 2022, has been remeasured in light of the subgroup's operating performance, which was lower than expected for the period from September 1, 2024 to August 31, 2025, and the downward revision of the projected operating performance assumptions for the period from September 1, 2025 to August 31, 2026. The impact of the remeasurement of this liability was recognized in other operating income in the amount of €1,286 thousand.

NOTE 15 – FINANCIAL INCOME AND EXPENSES

In thousands of euros June 30, 2024 Dec. 31, 2024 June 30, 2025
Interest on borrowings and similar expenses (6,432) (11,350) (4,749)
Income from marketable securities 2,914 5,649 2,410
Net finance costs (3,519) (5,701) (2,339)
Foreign exchange losses (1,538) (1,590) (6,893)
Foreign exchange gains 2,181 5,995 4,353
Other (1,345) (3,055) (814)
Other financial income and expenses (702) 1351 (3,354)
TOTAL (4,221) (4,350) (5,693)

{26}------------------------------------------------

NOTE 16 – INCOME TAX

The tax charge for the period is calculated by applying the estimated average effective tax rate to pre-tax income. This calculation is carried out individually for each of the Group's consolidated tax entities.

June 30, 2024 June 30, 2025
In thousands of euros Net income
before taxes
Net income tax
benefit/(expense)
Net income
before taxes
Net income tax
benefit/(expense)
French companies of the Group 25,832 (6,924) 30,491 (9,308)
Other Group companies 42,999 (9,983) 48,954 (11,435)
TOTAL 68,831 (16,907) 79,445 (20,743)
In thousands of euros June 30, 2024 Dec. 31, 2024 June 30, 2025
Current tax (18,031) (37,916) (19,376)
Net deferred tax 1,124 7,371 (1,367)
INCOME TAX (16,907) (30,545) (20,743)

Deferred tax assets and liabilities can be analyzed as follows:

In thousands of euros Dec. 31, 2024 June 30, 2025 Change
Deferred tax assets 6,744 5,730 (1,014)
Deferred tax liabilities 25,847 26,709 863
Net deferred tax (19,103) (20,979) (1,877)
In thousands of euros Dec. 31, 2024 June 30, 2025
Net deferred taxes at
January 1: assets/(liabilities)
(27,040) (19,103)
Recognized in equity 726 (86)
Changes in scope of consolidation 52
(Expense)/benefit 7,371 (1,367)
Translation adjustments (212) (423)
TOTAL (19,103) (20,979)
Of which deferred tax liabilities 25,847 26,709
Of which deferred tax assets 6,744 5,730

{27}------------------------------------------------

NOTE 17 – CASH AND CASH EQUIVALENTS

Net cash and cash equivalents (in thousands of euros) June 30, 2024 Dec. 31, 2024 June 30, 2025
Cash and cash equivalents 97,162 72,543 76,833
Marketable securities 64,460 85,591 69,804
Bank overdrafts (7,373) (2,223) (3,666)
TOTAL 154,249 155,910 142,970

Working capital requirement at the reporting date breaks down as follows:

Analysis of change in working capital
(in thousands of euros)
Dec. 31, 2024 Changes in exchange
rates and other
Cash flow June 30, 2025
Inventories and work in progress 247,618 (11,705) 9,883 245,795
Trade and other receivables 188,958 (7,105) 36,521 218,374
Trade and other payables (110,361) 5,111 (9,524) (114,774)
GROSS WORKING CAPITAL
REQUIREMENT
326,214 (13,699) 36,880 349,395
Impairment (17,798) 191 (381) (17,988)
NET WORKING CAPITAL REQUIREMENT 308,417 (13,508) 36,499 331,407

Marketable securities consist of certificates of deposit and other short-term investments, liquid investments and maturities of less than three months:

In thousands of euros Dec. 31, 2024 Movements Translation
adjustments
June 30, 2025
Marketable securities 85,591 (11,370) (4,417) 69,804

NOTE 18 – EARNINGS PER SHARE

The calculation of basic and diluted earnings per share at June 30, 2024, December 31, 2024 and June 30, 2025 is presented below:

Basic earnings June 30, 2024 Dec. 31, 2024 June 30, 2025
Net income attributable to owners of the Company (in thousands of euros) 51,688 90,068 58,501
Weighted average number of ordinary shares and investment certificates
outstanding (in thousands)
2,092 2,092 2,049
BASIC EARNINGS PER SHARE (IN EUROS) 24.71 43.06 28.55

{28}------------------------------------------------

Diluted earnings June 30, 2024 Dec. 31, 2024 June 30, 2025
Net income attributable to owners of the Company (in thousands of euros) 51,688 90,068 58,501
Weighted average number of ordinary shares and investment certificates
outstanding (in thousands)
2,092 2,092 2,049
Weighted average number of shares taken into account for the calculation of
diluted earnings per share (in thousands)
2092 2,092 2,049
DILUTED EARNINGS PER SHARE
(IN EUROS)
24.71 43.06 28.55

An investment certificate corresponds to a portion of the Company's capital that does not carry voting rights.

NOTE 19 – INFORMATION ON TRANSACTIONS WITH RELATED PARTIES

Transactions with affiliated companies solely correspond to purchases/sales of raw materials by the parent company from/to those companies. Transactions in the first half of the year represented purchases of €4,883 thousand and sales of €115 thousand, compared with purchases of €1,233 thousand and sales of €25 thousand in first-half 2024.

In addition, four free share plans were set up, authorized by the Board of Directors on April 11, 2025 and June 5, 2025:

Plan date Number of
shares
Vesting conditions Vesting date Availability
date
April 11, 2025 700 Free shares – not subject to performance conditions April 11, 2026 April 11, 2028
April 11, 2025 720 Free shares – subject to performance conditions April 11, 2028 April 11, 2030
June 5, 2025 307 Free shares – not subject to performance conditions June 5, 2026 June 5, 2028
June 5, 2025 797 Free shares – subject to performance conditions June 5, 2028 June 5, 2030

In addition, some of the free shares allocated in June 2022 and June 2024 vested during the period:

Plan date Number of
shares
Vesting conditions Vesting date Availability
date
June 12, 2024 964 Free shares – not subject to performance conditions June 12, 2025 June 12, 2027
June 14, 2022 785 Free shares – subject to performance conditions June 14, 2025 June 14, 2027

The IFRS 2 expense resulting from these plans recognized in first-half 2025 amounted to €1,056 thousand, compared with €1,314 thousand in first-half 2024.

See note 24 to the 2024 Annual Financial Report for more information on compensation.

NOTE 20 – SEASONALITY

The Group's business is not highly seasonal. However, the contribution of the first half to annual revenue is, as usual, slightly higher than that of the second half.

{29}------------------------------------------------

NOTE 21 – LIST OF CONSOLIDATED COMPANIES

Company Country % control Consolidation method
Robertet SA France Parent company
Robertet South Africa Aromatics Pty Ltd South Africa 100%
Robertet GmbH Germany 100%
Robertet Argentina S.A.I.C Argentina 100%
Robertet do Brasil Indústria e Comércio Ltda Brazil 100%
Robertet Bulgaria EOOD Bulgaria 100%
Robertet (Shanghai) International Trading Co. Ltd China 100%
Robertet Flavors & Fragrances (Beijing) Co. Ltd China 100%
Robertet Andina S.A.S Colombia 100%
Robertet Korea Ltd South Korea 100%
Robertet Middle East FZ LLD United Arab Emirates 100%
Aroma Esencial S.L. Spain 100%
Robertet España S.A. Spain 100%
Robertet USA Inc. United States 100%
Robertet Inc. United States 100% D
Robertet Flavors Inc. United States 100% E
Robertet Fragrances Creative Center Inc. United States 100% T
A
Phasex Corporation United States 100% D
LI
Robertet Canada Inc. Canada 100% O
Astier Demarest SAS France 90% S
N
Bionov SARL France 100% O
Robertet Bio SAS France 100% C
Y
Sirius SAS France 100% L
Villa Blu SAS France 100% L
U
Robertet Flavours & Fragrances India Pvt. Ltd India 100% F
Robertet India Private Ltd India 100%
Sonarome Private Ltd India 85%
PT Robertet Group Indonesia Indonesia 100%
Robertet Italia S.r.l Italy 100%
Robertet Japan Ltd Japan 100%
Robertet de Mexico S.A. de C.V Mexico 100%
Robertet UK Limited Ltd United Kingdom 100%
Maverick Active Holding Ltd United Kingdom 100%
Omega Ingredients Ltd United Kingdom 100%
Omega Corp United States 100%
Robertet Asia Pte Ltd Singapore 100%
Robertet SA Switzerland 100%
Robertet Gülyaği VE Itriyat Sanayi Ltd Şti. Turkey 100%
Hitex SAS France 50% Accounted for by the equity method

{30}------------------------------------------------

STATUTORY AUDITORS' REVIEW REPORT ON THE HALF-YEARLY FINANCIAL INFORMATION

For the period from January 1 to June 30, 2025

{31}------------------------------------------------

STATUTORY AUDITORS' REVIEW REPORT ON THE HALF-YEARLY FINANCIAL INFORMATION 2025

ROBERTET S.A.

For the period from January 1 to June 30, 2025

This is a free translation into English of the statutory auditors' review report on the half-yearly financial information issued in French and is provided solely for the convenience of English-speaking users. This report includes information relating to the specific verification of information given in the Group's half-yearly management report. This report should be read in conjunction with, and construed in accordance with, French law and professional standards applicable in France.

Robertet S.A. 37 Avenue Sidi Brahim 06130 Grasse Cedex

To the Shareholders,

In compliance with the assignment entrusted to us by your General Meeting and in accordance with the requirements of article L. 451-1-2 III of the French Monetary and Financial Code ("Code monétaire et financier"), we hereby report to you on:

  • the review of the accompanying condensed half-yearly consolidated financial statements of Robertet S.A., for the period from January 1, 2025 to June 30, 2025;
  • the verification of the information presented in the half-yearly management report.

These condensed half-yearly consolidated financial statements are the responsibility of the Board of Directors. Our role is to express a conclusion on these financial statements based on our review.

I - CONCLUSION ON THE FINANCIAL STATEMENTS

We conducted our review in accordance with professional standards applicable in France.

A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with professional standards applicable in France and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Based on our review, nothing has come to our attention that causes us to believe that the accompanying condensed half-yearly consolidated financial statements are not prepared, in all material respects, in accordance with IAS 34 standard of the IFRSs as adopted by the European Union applicable to interim financial information.

II. SPECIFIC VERIFICATION

We have also verified the information presented in the half-yearly management report on the condensed halfyearly consolidated financial statements subject to our review.

We have no matters to report as to its fair presentation and consistency with the condensed half-yearly consolidated financial statements.

The statutory auditors

Marseille, Lyon,

17 September 2025 KPMG S.A. 17 September 2025 COGEPARC S.A.

Loïc Herrmann Anne Brion Turck

Partner Partner

COGEPARC S.A. ROBERTET S.A.

KPMG S.A.

{32}------------------------------------------------

STATEMENT BY THE PERSONS RESPONSIBLE FOR THE INTERIM FINANCIAL REPORT

For the period from January 1, 2025 to June 30, 2025

{33}------------------------------------------------

PHILIPPE MAUBERT Chairman of the Board of Directors

JÉRÔME BRUHAT Chief Executive Officer

Grasse, September 10, 2025

STATEMENT BY THE PERSONS RESPONSIBLE FOR THE 2025 INTERIM FINANCIAL REPORT

We certify that, to the best of our knowledge, the half-yearly consolidated financial statements have been prepared in accordance with the applicable accounting standards and give a true and fair view of the assets, liabilities, financial position and profit or loss of the company and of all the companies included in the scope of consolidation, and that the interim management report attached hereto gives a true and fair view of significant events over the first six months of the year, the impact on the financial statements, the main transactions with related parties and a description of the main risks and uncertainties for the remaining six months of the year.

{34}------------------------------------------------

{35}------------------------------------------------